000 05870cam a2200625 i 4500
001 ocn868950997
003 OCoLC
005 20221128212408.0
006 m d
007 cr |||||||||||
008 130312s2013 nyua ob 001 0 eng
010 _a 2020678387
040 _aDLC
_beng
_erda
_cDLC
_dN$T
_dOCLCF
_dYDXCP
_dEBLCP
_dSTF
_dAU@
_dE7B
019 _a923548920
_a923670323
_a928194354
_a929143286
020 _a9781626185098
_q(eBook)
020 _a1626185093
020 _z1626184607
_q(hardback)
020 _z9781626184602
_q(hardback)
035 _a635078
_b(N$T)
035 _a(OCoLC)868950997
_z(OCoLC)923548920
_z(OCoLC)923670323
_z(OCoLC)928194354
_z(OCoLC)929143286
072 7 _aHEA
_x039000
_2bisacsh
072 7 _aMED
_x014000
_2bisacsh
072 7 _aMED
_x022000
_2bisacsh
072 7 _aMED
_x112000
_2bisacsh
072 7 _aMED
_x045000
_2bisacsh
049 _aMAIN
245 0 0 _aMuscular dystrophy :
_bcauses and management
_c
_h[E-Book]
264 1 _aNew York :
_bNova Biomedical,
_c[2013]
300 _a1 online resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
490 1 _aNeurodegenerative diseases--laboratory and clinical research
490 1 _aMuscular System - Anatomy, Functions and Injuries
504 _aIncludes bibliographical references and index.
588 _aDescription based on print version record.
505 0 _a""MUSCULAR DYSTROPHY. CAUSES AND MANAGEMENT""; ""MUSCULAR DYSTROPHY. CAUSES AND MANAGEMENT""; ""Library of Congress Cataloging-in-Publication Data""; ""Contents""; ""Preface""; ""Section 1. Genetic, Environmental Interactions and Evaluation""; ""Chapter 1: Muscular Dystrophy: The Present and Future""; ""Abstract""; ""The Present""; ""The Future""; ""Genetic and Environmental Interaction""; ""References""; ""Chapter 2: History and Pathogenesis of Muscular Dystrophy""; ""Introduction""; ""Muscular Dystrophy: Recognition of Different Forms""; ""Recognition of Severe X-Linked Muscular Dystrophy""
505 8 _a""The Nosographic Era: The Recognition of Limb-Girdle Dystrophies""""The Recognition of Facio-Scapulo Humeral Dystrophy (FSHD)""; ""Therapeutical Trials in DMD""; ""The Molecular Era""; ""References""; ""Chapter 3: Biomarkers and Genetic Risks""; ""Abstract""; ""Defining Biomarkers""; ""Biomarkers in Muscular Dystrophies""; ""Emerging Biomarkers""; ""Critical Parameters for the Choice of Biomarker Assay""; ""Conclusion""; ""References""; ""Chapter 4: Inflammation in Duchenne Muscular Dystrophy""; ""Introduction""; ""General Aspects of Dystrophic Muscle and the Immune Response""
505 8 _a""Hypothesis on a Putative Link between Functional Concepts of the Immune Response and Development of Fibrosis in DMD""""A View on Pathogenesis in DMD with Emphasis on Fibrosis and Inflammation""; ""Modeling DMD, Mediators and Drivers of the Immune Process �a�? What Can We Learn from the Mouse?""; ""Therapy Targeting Immune Processes""; ""Conclusion""; ""References""; ""Chapter 5: MRI Imaging in Muscular Dystrophies""; ""Abstract""; ""Introduction""; ""MRI Scoring and Interpretation""; ""Duchenne Muscular Dystrophy (DMD)""; ""Limb Girdle Muscular Dystrophies""; ""LGMD2A (Calpainopathy)""
505 8 _a""LGMD 2B (Dysferlinopathy)""""LGMD2I (FKRP Defect)""; ""Myotonic Dystrophy Type 1 (DM1)""; ""PROMM or Myotonic Dystrophy Type 2 (DM2)""; ""Congenital Muscular Dystrophies (CMD)""; ""Hyaline Body Myopathy (Scapulo-Peroneal Syndrome)""; ""Emery�a�?Dreifuss Muscular Dystrophy""; ""Bethlem Myopathy""; ""Future Perspectives""; ""References""; ""Chapter 6: Clinical Scales for the Evaluation of Neuromuscular Patients""; ""Abstract""; ""Motor Function""; ""Quality of Life""; ""References""; ""Section 2. Specific Dystrophies""; ""Chapter 7: Dystrophinopathies""; ""Abstract""
505 8 _a""Introduction: An Overview of Dystrophinopathies""""Clinical Description of DMD""; ""Clinical Description of BMD""; ""Clinical Description of Carriers""; ""Molecular Bases of Dystrophinopathies: The DMD Gene""; ""Molecular Bases of Dystrophinopathy: The Dystrophin Protein""; ""Molecular Bases of Dystrophinopathy: Pathogenesis""; ""Diagnosis of Dystrophinopathy""; ""Genetic Counseling and Prevention""; ""Treatment""; ""References""; ""Chapter 8: Scapulo-peroneal Syndromes""; ""Introduction""; ""Case Presentation""; ""Historical Perspective""; ""1. Scapuloperoneal Muscular Dystrophy (SPMD)""
520 _aMuscular Dystrophies include a heterogeneous series of diseases that range from childhood to adult onset cases, of difficult diagnosis and treatment. This book presents the state of the art in muscular dystrophies, after the molecular revolution. In the field of patients' diagnosis, several advances have been done by recognizing new entities. New techniques such as biochemical, molecular advancements, and the use of muscle MRI are collected that allow rapid diagnosis. Also, advances in therapy and therapeutical trials are presented in Duchenne and other muscular dystrophies and some novel trea.
590 _aMaster record variable field(s) change: 050, 082
650 0 _aMuscular dystrophy.
_97054
700 1 _aAngelini, C.
_q(Corrado),
_eeditor.
830 0 _aNeurodegenerative diseases--laboratory and clinical research.
830 0 _aMuscular system--anatomy, functions, and injuries series.
856 4 0 _uhttps://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=635078
_yKingston Hospital NHS Foundation Trust OpenAthens account holders click here for access
938 _aYBP Library Services
_bYANK
_n11120189
938 _aEBSCOhost
_bEBSC
_n635078
938 _aebrary
_bEBRY
_nebr10752217
938 _aProQuest Ebook Central
_bEBLB
_nEBL2194161
942 _n0
994 _a92
_bN$T
999 _c91417
_d91417